Logo image of PAVM

PAVMED INC (PAVM) Stock Fundamental Analysis

USA - NASDAQ:PAVM - US70387R4039 - Common Stock

0.4337 USD
-0.01 (-1.43%)
Last: 10/30/2025, 1:33:43 PM
Fundamental Rating

4

PAVM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. PAVM has a bad profitability rating. Also its financial health evaluation is rather negative. PAVM is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year PAVM was profitable.
In the past year PAVM has reported a negative cash flow from operations.
PAVM had negative earnings in 4 of the past 5 years.
In the past 5 years PAVM always reported negative operating cash flow.
PAVM Yearly Net Income VS EBIT VS OCF VS FCFPAVM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M -80M

1.2 Ratios

PAVM has a better Return On Assets (159.59%) than 100.00% of its industry peers.
PAVM has a better Return On Equity (171.73%) than 100.00% of its industry peers.
Industry RankSector Rank
ROA 159.59%
ROE 171.73%
ROIC N/A
ROA(3y)-87.06%
ROA(5y)-98.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PAVM Yearly ROA, ROE, ROICPAVM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K

1.3 Margins

PAVM has a better Profit Margin (6867.55%) than 100.00% of its industry peers.
PAVM does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 6867.55%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PAVM Yearly Profit, Operating, Gross MarginsPAVM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

More info and screens

2

2. Health

2.1 Basic Checks

PAVM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PAVM has more shares outstanding
The number of shares outstanding for PAVM has been reduced compared to 5 years ago.
The debt/assets ratio for PAVM has been reduced compared to a year ago.
PAVM Yearly Shares OutstandingPAVM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
PAVM Yearly Total Debt VS Total AssetsPAVM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -8.33, we must say that PAVM is in the distress zone and has some risk of bankruptcy.
PAVM has a worse Altman-Z score (-8.33) than 76.72% of its industry peers.
PAVM has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
PAVM's Debt to Equity ratio of 0.17 is in line compared to the rest of the industry. PAVM outperforms 59.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z -8.33
ROIC/WACCN/A
WACC6.24%
PAVM Yearly LT Debt VS Equity VS FCFPAVM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

PAVM has a Current Ratio of 0.52. This is a bad value and indicates that PAVM is not financially healthy enough and could expect problems in meeting its short term obligations.
PAVM has a Current ratio of 0.52. This is amonst the worse of the industry: PAVM underperforms 92.59% of its industry peers.
A Quick Ratio of 0.52 indicates that PAVM may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.52, PAVM is doing worse than 91.53% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52
PAVM Yearly Current Assets VS Current LiabilitesPAVM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

7

3. Growth

3.1 Past

PAVM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 116.58%, which is quite impressive.
The Revenue for PAVM has decreased by -73.35% in the past year. This is quite bad
PAVM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 81.61% yearly.
EPS 1Y (TTM)116.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.82%
Revenue 1Y (TTM)-73.35%
Revenue growth 3Y81.61%
Revenue growth 5YN/A
Sales Q2Q%-99.39%

3.2 Future

Based on estimates for the next years, PAVM will show a very strong growth in Earnings Per Share. The EPS will grow by 26.79% on average per year.
PAVM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 142.05% yearly.
EPS Next Y108.83%
EPS Next 2Y26.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-96.01%
Revenue Next 2Y-63.49%
Revenue Next 3Y268.29%
Revenue Next 5Y142.05%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PAVM Yearly Revenue VS EstimatesPAVM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
PAVM Yearly EPS VS EstimatesPAVM Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -5 -10 -15

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 0.33, the valuation of PAVM can be described as very cheap.
Based on the Price/Earnings ratio, PAVM is valued cheaper than 100.00% of the companies in the same industry.
PAVM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.76.
The Forward Price/Earnings Ratio is negative for PAVM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 0.33
Fwd PE N/A
PAVM Price Earnings VS Forward Price EarningsPAVM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PAVM Per share dataPAVM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

PAVM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PAVM's earnings are expected to grow with 26.79% in the coming years.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y26.79%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PAVM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PAVMED INC

NASDAQ:PAVM (10/30/2025, 1:33:43 PM)

0.4337

-0.01 (-1.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-11 2025-11-11
Inst Owners10.64%
Inst Owner Change0%
Ins Owners4.91%
Ins Owner Change15.5%
Market Cap9.22M
Revenue(TTM)1.02M
Net Income(TTM)70.05M
Analysts82.5
Price Target11.73 (2604.63%)
Short Float %2.54%
Short Ratio1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-50.83%
Min EPS beat(2)-458.07%
Max EPS beat(2)356.41%
EPS beat(4)2
Avg EPS beat(4)4.93%
Min EPS beat(4)-458.07%
Max EPS beat(4)356.41%
EPS beat(8)4
Avg EPS beat(8)-2.84%
EPS beat(12)7
Avg EPS beat(12)1.55%
EPS beat(16)7
Avg EPS beat(16)-3.09%
Revenue beat(2)0
Avg Revenue beat(2)-31.37%
Min Revenue beat(2)-41.18%
Max Revenue beat(2)-21.57%
Revenue beat(4)0
Avg Revenue beat(4)-42.93%
Min Revenue beat(4)-98.31%
Max Revenue beat(4)-10.67%
Revenue beat(8)1
Avg Revenue beat(8)-22.75%
Revenue beat(12)2
Avg Revenue beat(12)-30.74%
Revenue beat(16)2
Avg Revenue beat(16)-36.71%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.25%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-66.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 0.33
Fwd PE N/A
P/S 9.04
P/FCF N/A
P/OCF N/A
P/B 0.23
P/tB 0.23
EV/EBITDA N/A
EPS(TTM)1.33
EY306.66%
EPS(NY)-0.82
Fwd EYN/A
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.54
OCFYN/A
SpS0.05
BVpS1.92
TBVpS1.92
PEG (NY)0
PEG (5Y)N/A
Graham Number7.58
Profitability
Industry RankSector Rank
ROA 159.59%
ROE 171.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 6867.55%
GM N/A
FCFM N/A
ROA(3y)-87.06%
ROA(5y)-98.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.45%
Cap/Sales 2.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z -8.33
F-Score4
WACC6.24%
ROIC/WACCN/A
Cap/Depr(3y)25.15%
Cap/Depr(5y)202.92%
Cap/Sales(3y)138.99%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.82%
EPS Next Y108.83%
EPS Next 2Y26.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-73.35%
Revenue growth 3Y81.61%
Revenue growth 5YN/A
Sales Q2Q%-99.39%
Revenue Next Year-96.01%
Revenue Next 2Y-63.49%
Revenue Next 3Y268.29%
Revenue Next 5Y142.05%
EBIT growth 1Y54.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year114.99%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y82.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.3%
OCF growth 3YN/A
OCF growth 5YN/A

PAVMED INC / PAVM FAQ

What is the fundamental rating for PAVM stock?

ChartMill assigns a fundamental rating of 4 / 10 to PAVM.


Can you provide the valuation status for PAVMED INC?

ChartMill assigns a valuation rating of 4 / 10 to PAVMED INC (PAVM). This can be considered as Fairly Valued.


Can you provide the profitability details for PAVMED INC?

PAVMED INC (PAVM) has a profitability rating of 3 / 10.


Can you provide the financial health for PAVM stock?

The financial health rating of PAVMED INC (PAVM) is 2 / 10.


Can you provide the dividend sustainability for PAVM stock?

The dividend rating of PAVMED INC (PAVM) is 0 / 10 and the dividend payout ratio is 0%.